Showing results (431-440 of 1,017) with videos related to

Sort By:
Pageof 102
Journal of Nanoscience and Nanotechnology|April 1, 2011
FeTaC magnetic soft underlayer for L1(0) FePt based perpendicular recording mediaP W Lwin, J F Hu, B C Lim, et al.
The Journal of Trauma and Acute Care Surgery|June 8, 2012
Traditional systolic blood pressure targets underestimate hypotension-induced secondary brain injuryMegan Brenner, Deborah M Stein, Peter F Hu, et al.
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|June 1, 1997
Fixed-duration multidrug therapy in multibacillary leprosyH Y Li, L F Hu, P W Wu, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
Regulation of MDR1 gene expression: emerging conceptsPhillip Kantharidis, Sam El-Osta, Michelle de Silva, et al.
Neuroscience|February 13, 2010
Hydrogen sulfide protects neurons against hypoxic injury via stimulation of ATP-sensitive potassium channel/protein kinase C/extracellular signal-regulated kinase/heat shock protein 90 pathwayA S Tay, L F Hu, M Lu, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|May 3, 2017
[The impact of broadened diagnostic criteria on the prevalence of hypertension, hyperlipidemia and diabetes mellitus in China]X F Hu, X R Han, Z Y Yang, et al.
Cancer Research|September 29, 1998
Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcriptsG A Ulaner, J F Hu, T H Vu, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|November 26, 2023
[Association between different treatment timings and adverse neonatal outcomes in pregnant women with syphilis during pregnancy]F Hu, Z Q Huang, M Cai, et al.
Neuromuscular Disorders : NMD|November 6, 2017
Early onset facioscapulohumeral dystrophy - a systematic review using individual patient dataRianne J M Goselink, Nicol C Voermans, Kees Okkersen, et al.
JAMA Neurology|May 27, 2020
Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical TrialPaula R Clemens, Vamshi K Rao, Anne M Connolly, et al.
Pageof 102